Patents by Inventor Richard Miller

Richard Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137073
    Abstract: An orthosis is fitted to a body joint, in a preferred embodiment the equine fetlock, by locating the center of rotation (COR) of the joint; measuring the bones comprising the joint at points located with respect to the COR; selecting the appropriate orthosis from a selection of models thereof; and custom-fitting the orthosis to the individual by heating it to soften a layer of thermoformable foam on the interior of the orthosis and clamping the orthosis in place over the body joint. A kit of tools for performing the measurements is disclosed, as are a method for location of the COR of the body joint by palpation and a preferred heater.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 13, 2021
    Applicant: Horsepower Technologies Inc.
    Inventors: Mouli Ramani, Victoria Thompson, Keith Sproat, Kristin Size, Richard Miller, Carl Kirker-Head, Geralyn Schad, Evan Williams
  • Publication number: 20210130242
    Abstract: A coated ceramic honeycomb body comprising a honeycomb structure comprising a matrix of intersecting porous walls forming a plurality of axially-extending channels, at least some of the plurality of axially-extending channels being plugged to form inlet channels and outlet channels, wherein a total surface area of the outlet channels is greater than a total surface area of the inlet channels, and wherein a catalyst is preferentially located within the outlet channels, and preferentially disposed on non-filtration walls of the outlet channels. Methods and apparatus configured to preferentially apply a catalyst-containing slurry to the outlet channels and non-filtration walls are provided, as are other aspects.
    Type: Application
    Filed: May 3, 2019
    Publication date: May 6, 2021
    Inventors: Douglas Munroe Beall, Achim Karl-Erich Heibel, Konstantin Vladimirovich Khodosevich, Kenneth Richard Miller, Hrushikesh Govindrao Pimpalgaonkar, Kunal Upendra Sakekar, Min Shen, Todd Parrish St Clair
  • Patent number: 10987348
    Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: April 27, 2021
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Sara Sabina Hadida Ruah, Peter Diederik Jan Grootenhuis, Fredrick F. Van Goor, Jinglan Zhou, Brian Richard Bear, Mark Thomas Miller, Jason McCartney, Mehdi Michel Djamel Numa
  • Patent number: 10987815
    Abstract: Systems, apparatus, and methods of manufacturing an article using electroadhesion technology, either as a sole modality of handling such materials or in concert with at least one mechanically actuated modality for the pick-up and release of materials, respectively. The mechanically actuated modality in one embodiment is configured as a netting configured to be placed over a contact surface of an electroadhesive plate to facilitate the handling of an object.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: April 27, 2021
    Assignee: Grabit, Inc.
    Inventors: Harsha Prahlad, Richard J. Casler, Susan Kim, Matthew Leettola, Jon Smith, Kenneth Tan, Patrick Wang, John Mathew Farren, Patrick Conall Regan, Po Cheng Chen, Howard Fu, Honam Ko, Dragan Jurkovic, Aishwarya Varadhan, Tsung Tai Chien, Chang-Chu Liao, Chih-Chi Chang, Kuo-Hung Lee, Ming-Feng Jean, TaeHoun Kim, Qingde Chen, Greg Miller
  • Publication number: 20210091815
    Abstract: The disclosure relates to technology for an apparatus having a current conveyer comprising a first stage having a first differential input, and a second stage having a second differential input. The first and second stages are configured to operate in a push-pull mode to provide an output signal at a current conveyer output between the first stage and the second stage. The apparatus has a first frequency mixer configured to generate a first mixer signal based on an input signal and an oscillator signal having a first frequency. The first frequency mixer is configured to provide the first mixer signal to the first differential input. The apparatus has a second frequency mixer configured to generate a second mixer signal based on the input signal and a second oscillator signal having the first frequency. The second frequency mixer is configured to provide the second mixer signal to the second differential input.
    Type: Application
    Filed: December 9, 2020
    Publication date: March 25, 2021
    Applicant: Huawei Technologies Co., Ltd.
    Inventors: Matthew Richard Miller, Brian Creed, Terrie McCain
  • Publication number: 20210078265
    Abstract: Disclosed herein is an automated fiber placement system that comprises a robot, an end effector, and a creel assembly that is coupled to the robot and movable with the robot. The creel assembly comprises a spool of a tow and a tow tensioner. The tow tensioner comprises an arm assembly that is pivotable toward and away from a tow direction between a forward position and a rearward position, inclusive, and configured to secure the tow from the spool as the tow unwinds from the spool and moves in the tow direction. The tow tensioner also comprises a biasing member that is coupled to the arm assembly and configured to bias the arm assembly into a neutral position between the forward position and the rearward position. The tow tensioner additionally comprises a potentiometer that is coupled to the arm assembly and configured to detect a position of the arm assembly.
    Type: Application
    Filed: September 12, 2019
    Publication date: March 18, 2021
    Inventor: Richard A. Miller
  • Patent number: 10938624
    Abstract: A method includes collecting operational data from a system, segregating the data into a first component comprising one or more service quality anomalies and a second component comprising one or more network-based events, correlating the first component and the second component to determine whether the one or more network-based events have an impact on service quality, and prioritizing a resolution of the network-based events that have an impact on service quality.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: March 2, 2021
    Assignees: AT&T Intellectual Property I, L.P., AT&T Mobility II LLC
    Inventors: He Yan, Zihui Ge, Giritharan Rana, Heather Magrini, Jennifer Yates, Matthew Osinski, Brandon Hall, Edward Ball, Richard Miller, Kathryn W. Childs
  • Publication number: 20210055244
    Abstract: There is provided a method for determining a quality of an abrasive surface preparation of a composite surface, prior to the composite surface undergoing a post-processing operation. The method includes fabricating levels of abrasive surface preparation standards for a reference composite surface; using a surface analysis tool in the form of an ohm meter, to create target values for quantifying the levels; and measuring, with the surface analysis tool, one or more abrasive surface preparation locations on the composite surface of a test composite structure, to measure one or more of, electrical resistance and surface resistivity, of the composite surface, to obtain test result measurement(s). The method further includes comparing the test result measurement(s) to the levels, to obtain test result level(s); determining if the test result level(s) meet the target value(s); and determining whether the composite surface is acceptable to proceed with the post-processing operation.
    Type: Application
    Filed: August 19, 2019
    Publication date: February 25, 2021
    Inventors: Eileen O. Kutscha, Tyler J. Zimmerman, Richard A. Miller, II, Kay Y. Blohowiak
  • Patent number: 10912776
    Abstract: Provided herein are, inter alia, methods of treating cancer by administering to a subject a therapeutically effective amount of an adenosine-A2A(A2A) receptor antagonist or a combination of an adenosine-A2A(A2A) receptor antagonist and a programmed cell death protein 1(PD-1) signaling pathway inhibitor. Further provided are pharmaceutical compositions including an A2A receptor antagonist, a PD-1 signaling pathway inhibitor and a pharmaceutically acceptable excipient. Further provided are methods of detecting cellular effects, for example expression of pCREB, before, after or during adenosine receptor antagonist treatment.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: February 9, 2021
    Assignee: CORVUS PHARMACEUTICALS, INC.
    Inventors: Stephen Willingham, Richard A. Miller, Po Y. Ho, Ian McCaffery, Andrew Hotson
  • Publication number: 20210031178
    Abstract: A honeycomb body (300) including a plurality of radially-extending walls (322) intersecting with a plurality of circumferentially-extending walls (324), the plurality of radially-extending walls (322) and the plurality of circumferentially-extending walls (324) form a plurality of circumferential zones (334A, 334B, 334C) of cells (308). The plurality of circumferential zones (334A, 334B, 334C) of cells (308) includes a first zone of cells (334A) including two or more first rings of cells (330) and having a first cell density, and a second zone of cells (334B) including two or more rings of cells (330) having varying cell densities across the two or more rings of cells. Other structures and extrusion dies are disclosed.
    Type: Application
    Filed: March 28, 2019
    Publication date: February 4, 2021
    Inventors: Douglas Munroe Beall, Priyank Paras Jain, Kenneth Richard Miller, Artemii Alexandrovitch Shamkin
  • Publication number: 20210008206
    Abstract: Provided herein are, inter alia, methods for treating cancer in subjects expressing elevated levels of adenosine A2A receptors, and optionally further expressing elevated levels of CD73 and/or PD-L1, by administering adenosine pathway inhibitors.
    Type: Application
    Filed: November 6, 2018
    Publication date: January 14, 2021
    Inventors: Richard A. Miller, Ian Mccaffery, Andrew Hotson
  • Patent number: 10870652
    Abstract: Provided herein, inter alia, are compounds and methods for modulating Bruton's Tyrosine Kinase.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: December 22, 2020
    Assignee: CORVUS PHARMACEUTICALS, INC.
    Inventors: Ryan Hudson, Anne-Marie Beausoleil, Richard A. Miller, Erik Verner
  • Patent number: 10828052
    Abstract: There is disclosed a tool kit including differently sized and shaped tongue-cleaning working tips. The working tips generally include a distal working blade for engagement with the surface of the tongue. In some embodiments, the distal working blades are planar and may include one or more bends between planar sections or portions. In other embodiments of the tongue-cleaning working tips, the working blades are curved. The tongue-cleaning working tips may optionally include a proximal mounting stem extending proximally from the distal working blade to allow for better access to certain regions of the tongue. Additionally, the distal working blades of the tongue-cleaning working tips may be tapered to further reach desired areas of the tongue.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: November 10, 2020
    Inventor: Richard A. Miller
  • Publication number: 20200351149
    Abstract: A method includes collecting operational data from a system, segregating the data into a first component comprising one or more service quality anomalies and a second component comprising one or more network-based events, correlating the first component and the second component to determine whether the one or more network-based events have an impact on service quality, and prioritizing a resolution of the network-based events that have an impact on service quality.
    Type: Application
    Filed: April 30, 2019
    Publication date: November 5, 2020
    Inventors: He Yan, Zihui Ge, Giritharan Rana, Heather Magrini, Jennifer Yates, Matthew Osinski, Brandon Hall, Edward Ball, Richard Miller, Kathryn W. Childs
  • Patent number: 10822426
    Abstract: Provided herein are, inter alia, humanized 1E9 antibodies capable of binding CD73. The humanized antibodies are useful for the treatment of cancer. Further provided are nucleic acids encoding humanized 1E9 antibodies and methods of inhibiting cell proliferation using the humanized antibodies provided herein.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 3, 2020
    Assignees: CORVUS PHARMACEUTICALS, INC., BIOATLA, LLC
    Inventors: Emily Piccione Griffin, Richard A. Miller, Gerhard Johann Frey, Hwai Wen Chang
  • Publication number: 20200333843
    Abstract: According to an aspect of the disclosure, an auxiliary monitor system is provided. The auxiliary monitor system includes a first auxiliary monitor configured to be coupled to a primary monitor, a second auxiliary monitor, and at least one fastener configured to removably couple the first auxiliary monitor to the second auxiliary monitor.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Inventors: Xiaoliang Yao, Wenglong Ng, Richard Miller, Brian Yoo, Evan Hunter Williams
  • Publication number: 20200321479
    Abstract: Embodiments are provided herein for low loss coupling capacitor structures. The embodiments include a n-type varactor (NVAR) configuration and p-type varactor (PVAR) configuration. The structure in the NVAR configuration comprises a p-doped semiconductor substrate (Psub), a deep n-doped semiconductor well (DNW) in the Psub, and a p-doped semiconductor well (P well) in the DNW. The circuit structure further comprises a source terminal of a p-doped semiconductor material within P well, and a drain terminal of the p-doped semiconductor material within the P well. Additionally, the circuit structure comprises an insulated gate on the surface of the P well, a metal pattern comprising a plurality of layers of metal lines, and a plurality of vias through the metal lines. The vias are contacts connecting the metal lines to the gate, the source terminal, and the drain terminal.
    Type: Application
    Filed: March 9, 2020
    Publication date: October 8, 2020
    Applicant: Futurewei Technologies, Inc.
    Inventors: Brian Creed, Lawrence E. Connell, Kent Jaeger, Matthew Richard Miller
  • Patent number: 10793636
    Abstract: Provided herein are, inter alia, anti-CD73 antibodies and methods of using the same. The antibodies provided include amino acid substitution embodiments affecting the antibody glycosylation state. The antibodies provided herein are, inter alia, useful for the treatment of cancer and effective for inhibition of CD73 activity.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: October 6, 2020
    Assignee: CORVUS PHARMACEUTICALS, INC.
    Inventors: Emily Piccione Griffin, Richard A. Miller, Ian McCaffery
  • Publication number: 20200298441
    Abstract: Methods of manufacturing honeycomb-structure-forming extrusion dies having a number of slots for use in producing extruded articles having complex honeycomb patterns and extrusion dies for use in the manufacture of extruded honeycomb bodies. The method includes inserting a die insert having a runner and a number of teeth into a slot of an extrusion die such that each of the teeth blocks at least a portion of the slot of the extrusion die. The method further includes separating the runner from the teeth so that the teeth remain within the slot of the extrusion die.
    Type: Application
    Filed: February 13, 2020
    Publication date: September 24, 2020
    Inventors: Douglas Munroe Beall, Kenneth Richard Miller, David John Thompson
  • Publication number: 20200297728
    Abstract: Provided herein are, inter alia, methods of treating a cancer tumor in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an adenosine A2A receptor antagonist, wherein the subject comprises an elevated level of CD8+ tumor infiltrating lymphocytes relative to a control, the subject comprises an elevated level of T-effector gene signature relative to a control, the subject comprises an increased cancer tumor T cell receptor diversity or blood T cell receptor diversity relative to a control, the cancer tumor comprises an elevated level of PD-L1 relative to a control, and/or the cancer tumor or the blood of the subject comprises an elevated level of CD73 relative to a control. Further provided are, inter alia, methods for determining whether a subject is likely to, is, or has responded to anti-cancer therapy comprising an A2A receptor antagonist.
    Type: Application
    Filed: April 4, 2018
    Publication date: September 24, 2020
    Inventors: Andrew Hotson, Richard A. Miller, Ian Mccaffery, Stephen Willingham